Market Cap for AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported market cap is $405.34B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingMarket CapSwitch metric
Latest period
$405.34B
YoY change
-10.8%
5Y CAGR
+8.5%
Peak year (2025)
$405.34B
Latest annual
$361.70B
Market Cap history chart for AbbVie (ABBV) from 2012 to 2026
Market Cap history table for AbbVie (ABBV) from 2012 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $361.70B | -10.8% | ||
| 2025 | $405.34B | +28.7% | ||
| 2024 | $315.06B | +14.7% | ||
| 2023 | $274.76B | -4.4% | ||
| 2022 | $287.34B | +19.4% | ||
| 2021 | $240.61B | +34.2% | ||
| 2020 | $179.26B | +36.4% | ||
| 2019 | $131.39B | -7.8% | ||
| 2018 | $142.53B | -8.1% | ||
| 2017 | $155.03B | +51.8% | ||
| 2016 | $102.13B | +5.3% | ||
| 2015 | $96.98B | -8.0% | ||
| 2014 | $105.36B | +24.4% | ||
| 2013 | $84.71B | +57.2% | ||
| 2012 | $53.87B | — |
Market Cap values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2026's annual market cap for AbbVie (ABBV) came in at $361.70B – declined 10.8% year-over-year.
Looking at the 2021–2026 (5 years) stretch, AbbVie market cap compounded at +8.5% per year, with the latest reading among the more recent periods of the dataset.
Between 2025 and 2026, AbbVie market cap declined 10.8%, falling from $405.34B to $361.70B.
Across the available history, market cap reached its high of $405.34B in 2025 and its low of $53.87B in 2012.
Within Healthcare, AbbVie (ABBV) ranks 3rd among 8 peers we track. The peer median for market cap is $280.76B.
AbbVie Market Cap by Year
AbbVie Market Cap 2026: $361.70B
AbbVie market cap in 2026 was $361.70B, declined 10.8% below 2025.
AbbVie Market Cap 2025: $405.34B
AbbVie market cap in 2025 was $405.34B, grew 28.7% from 2024. This figure represents the highest annual value in the available history.
AbbVie Market Cap 2024: $315.06B
AbbVie market cap in 2024 was $315.06B, grew 14.7% from 2023.
AbbVie Market Cap 2023: $274.76B
AbbVie market cap in 2023 was $274.76B, edged down 4.4% below 2022.
AbbVie Market Cap 2022: $287.34B
AbbVie market cap in 2022 was $287.34B.
See more financial history for AbbVie (ABBV).
Sector peers — Market Cap
Companies in the same sector as AbbVie, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $174.74B | Healthcare |
Frequently asked questions
What is AbbVie's market cap?
- Latest reported market cap for AbbVie (ABBV) is $405.34B (period ending December 31, 2025).
How has AbbVie market cap changed year-over-year?
- AbbVie (ABBV) market cap changed -10.8% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie market cap?
- AbbVie (ABBV) market cap compound annual growth rate is +8.5% over the most recent 5 years available.
When did AbbVie market cap hit its highest annual value?
- AbbVie market cap reached its highest annual value of $405.34B in 2025.
What was AbbVie market cap in 2025?
- AbbVie (ABBV) market cap in 2025 was $405.34B.
What was AbbVie market cap in 2026?
- AbbVie (ABBV) market cap in 2026 was $361.70B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,939 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $134.01 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $61.16B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.5% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.24% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 3.31%. Safety: 6/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.